1-(2-Hydroxyethyl)piperazine → HCID 58614686, compound
Reaction equation
Cl[S:2]([C:5]1[CH:13]=[CH:12][C:8]([C:9]([OH:11])=O)=[CH:7][CH:6]=1)(=[O:4])=[O:3].[N:14]1([CH2:20][CH2:21][OH:22])[CH2:19][CH2:18][NH:17][CH2:16][CH2:15]1.[Cl:23][C:24]1[CH:30]=[CH:29][C:27]([NH2:28])=[CH:26][C:25]=1[C:31]1[CH:36]=[CH:35][CH:34]=[CH:33][N:32]=1.OCCCN1CCN(S(C2C=CC(C(O)=O)=CC=2)(=O)=O)CC1>>[Cl:23][C:24]1[CH:30]=[CH:29][C:27]([NH:28][C:9](=[O:11])[C:8]2[CH:7]=[CH:6][C:5]([S:2]([N:17]3[CH2:18][CH2:19][N:14]([CH2:20][CH2:21][OH:22])[CH2:15][CH2:16]3)(=[O:3])=[O:4])=[CH:13][CH:12]=2)=[CH:26][C:25]=1[C:31]1[CH:36]=[CH:35][CH:34]=[CH:33][N:32]=1Participants
5
Procedure
1 g of 4-(chlorosulfonyl)benzoic acid was reacted with 615 μL of 2-(piperazin-1-yl)ethanol via Procedure H. 75 mg of 4-chloro-3-(pyridin-2-yl)aniline was coupled to 125 mg of 4-(4-(3-hydroxypropyl)piperazin-1-ylsulfonyl)benzoic acid by Procedure G and purified by reverse phase HPLC to yield N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(4-(2-hydroxyethyl)piperazin-1-ylsulfonyl)benzamide. MS (Q1) 501.3 (M)+.
Workup
- custompurified by reverse phase HPLC
Sources & evidence
- ORD record
- ord-8b078de377d4466a9df8b736d2f00486
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09278961B2
Reaction notes
Loading…